[ Price : $8.95]
CDRH warns Canadas Ophthalmic Technologies for QS and MDR violations and says an Import Alert has been issued for its devices.[ Price : $8.95]
FDA reports that GlaxoSmithKline has resumed normal supply shipments of argatroban for injection that had been in short supply due...[ Price : $8.95]
Reps. John Dingell and Bart Stupak say FDA has not delivered all records and materials requested for a committee probe into a cont...[ Price : $8.95]
FDA extends by three months its review of a Wilmington Pharmaceuticals NDA for Metozolv orally disintegrating tablets.[ Price : $8.95]
FDA advisors say that Alpharma abuse-prevention plans for Embeda could deter some, but not all, potential abusers.[ Price : $8.95]
FDA approves an Eisai Corp. NDA for Banzel (rufinamide), indicated as adjunctive treatment of seizures associated with Lennox-Gast...[ Price : $8.95]
Altus Pharmaceuticals says it plans to submit an NDA for Trizytek (liprotamase) during the first-half of 2009.[ Price : $8.95]
FDA reports that Merck continues to experience shipping delays for Zostavax (zoster vaccine live).